Akathisia
| Akathisia | |
|---|---|
| Synonyms | N/A |
| Pronounce | N/A |
| Specialty | N/A |
| Symptoms | Inner restlessness, inability to stay still |
| Complications | Anxiety, depression, suicide |
| Onset | Minutes to weeks after starting or increasing dose of antipsychotic medication |
| Duration | Variable, can persist for weeks to months |
| Types | N/A |
| Causes | Antipsychotic medications, SSRIs, other medications |
| Risks | High doses of antipsychotics, rapid dose escalation, history of akathisia |
| Diagnosis | Clinical evaluation |
| Differential diagnosis | Restless legs syndrome, tardive dyskinesia, anxiety disorder |
| Prevention | N/A |
| Treatment | Reducing or discontinuing the causative medication, beta blockers, benzodiazepines |
| Medication | Propranolol, lorazepam, mirtazapine |
| Prognosis | N/A |
| Frequency | Common in patients on antipsychotics |
| Deaths | N/A |
Akathisia is a movement disorder that manifests as a feeling of inner restlessness and the inability to stay still. It's a common side effect of certain medications, particularly antipsychotics.<ref>Miller, CH, The spectrum of akathisia, Journal of Neuropsychiatry and Clinical Neurosciences, 1994, Vol. 6(Issue: 1), pp. 100-109, DOI: 10.1176/jnp.6.1.100,</ref>

Clinical Presentation[edit]
Individuals with akathisia experience a compelling urge to move, often accompanied by uncomfortable sensations in the legs. This can manifest as rocking while standing or sitting, lifting the feet as if marching on the spot, crossing and uncrossing the legs, and pacing around.<ref>Barnes, TRE,
A Rating Scale for Drug-Induced Akathisia, British Journal of Psychiatry, 1989, Vol. 154(Issue: 5), pp. 672-676, DOI: 10.1192/bjp.154.5.672,</ref>
Causes[edit]
The most common cause of akathisia is medication, especially antipsychotic drugs. Other drugs, including certain antiemetics and antidepressants, can also cause akathisia. In some cases, akathisia can be a symptom of Parkinson's disease or a side effect of its treatment.
Diagnosis[edit]
Akathisia is usually diagnosed based on the patient's symptoms and history, especially the use of drugs associated with this condition. Various rating scales, such as the Barnes Akathisia Rating Scale (BARS), can be used to quantify the severity of symptoms.<ref>Sachdev, P,
The development of the concept of akathisia: a historical overview, Schizophrenia Research, 1995, Vol. 14(Issue: 2), pp. 117-28, DOI: 10.1016/0920-9964(94)00056-4,</ref>
Management[edit]
Management strategies for akathisia include reducing the dose or discontinuing the offending drug, if possible. Other treatments include the use of drugs such as benzodiazepines, beta blockers, or anticholinergics to manage symptoms. In severe cases, hospitalization may be required.
Prognosis[edit]
With appropriate management, symptoms of akathisia can often be significantly reduced or eliminated. However, if left untreated, this condition can lead to distress, anxiety, and depression.<ref>Hansen, L,
Extrapyramidal symptoms and signs in first-episode, drug-naive patients with schizophrenia, Acta Psychiatrica Scandinavica, 2005, Vol. 111(Issue: 1), pp. 67-73, DOI: 10.1111/j.1600-0447.2004.00423.x,</ref>
Epidemiology[edit]
The incidence of akathisia varies significantly depending on the population studied and the specific medications used. It's particularly common among individuals receiving antipsychotic medication, with studies reporting incidences ranging from 20% to 75%.<ref>Kane, JM,
Tardive dyskinesia rates with atypical antipsychotics in adults: prevalence and incidence, Journal of Clinical Psychiatry, 2001, Vol. 62(Issue: Suppl 4), pp. 21-31,</ref>
Research Directions[edit]
Despite significant advances in understanding the underlying mechanisms of akathisia, much remains unknown about this condition. Current research efforts are focused on identifying more effective treatment strategies and understanding the biological basis of drug-induced akathisia.
See Also[edit]
References[edit]
<references/>
|
|
|
| Diseases of the nervous system, primarily CNS (G04–G47, 323–349) | ||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Ad. Transform your life with W8MD's
GLP-1 weight loss injections special from $29.99


W8MD Medical Weight Loss, Sleep and Medspa offers physician-supervised medical weight loss programs: NYC medical weight loss Philadelphia medical weight loss
Affordable GLP-1 Weight Loss ShotsAffordable GLP-1 Weight Loss Shots
Budget GLP-1 injections NYC (insurance & self-pay options) Popular treatments:
- Semaglutide starting from $29.99/week
- Tirzepatide starting from $45.00/week
✔ Most insurances accepted for visits ✔ Prior authorization support when eligible
Start your physician weight loss NYC journey today:
📍 NYC: Brooklyn weight loss center 📍 Philadelphia: Philadelphia weight loss center
📞 Call: 718-946-5500 (NYC) | 215-676-2334 (Philadelphia)
Tags: Affordable GLP1 weight loss NYC, Wegovy NYC, Zepbound NYC, Philadelphia medical weight loss
|
WikiMD Medical Encyclopedia |
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian


